Notably, PEOs modulate key targets such as SLC6A4 (serotonin transporter) and SLC6A3 (dopamine transporter), regulating serotonergic and dopaminergic synaptic pathways and thereby alleviating menopause-associated depression [19]. Here, SLC6A3 is linked to depressive symptom measurement.